Market Trends J&J boasts Rybrevant, Lazcluze combo bests AstraZeneca’s TagrissoBy admin8996erT0allMarch 26, 2025 yuelan Johnson & Johnson (NYSE:JNJ) said that data from a phase 3 trial indicated that a combination of Rybrevant (amivantamab)…
Market Trends Apple’s iPhone 16 now boasts five models with 16e release (AAPL:NASDAQ)By admin8996erT0allFebruary 22, 2025 Peter NichollsApple (NASDAQ:AAPL) releases the iPhone 16e on February 28, giving consumers five iPhone 16 models to choose from. The…
